Spravato® (esketamine)
FDA-approved prescription nasal spray used together with an oral antidepressant to treat adults with treatment-resistant depression (TRD) and certain adults with major depressive disorder (MDD)
Benefits
-
May provide relief when other antidepressants have not been effective.
-
Can improve symptoms of depression in eligible patients.
-
Works through a different mechanism than traditional antidepressants.
-
Administered under the supervision of trained healthcare professionals.
-
May help patients regain daily functioning and improve quality of life.
A New Option for Treatment-Resistant Depression
If you or a loved one is struggling with depression that has not responded to traditional treatments, ask our healthcare team whether Spravato® may be an appropriate option.
Who Is It For?
Spravato® may be appropriate for adults who:
-
Have treatment-resistant depression (depression that has not improved after trying at least two antidepressants).
-
Have major depressive disorder with acute suicidal thoughts or behaviors, when determined appropriate by a healthcare provider.